151 related articles for article (PubMed ID: 7562403)
1. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
Nolen H; Fedorak RN; Friend DR
J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
Haeberlin B; Rubas W; Nolen HW; Friend DR
Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of corticosteroid delivery from glucuronide prodrugs in normal and colitic rats.
Nolen HW; Fedorak RN; Friend DR
Biopharm Drug Dispos; 1997 Nov; 18(8):681-95. PubMed ID: 9373725
[TBL] [Abstract][Full Text] [Related]
4. A budesonide prodrug accelerates treatment of colitis in rats.
Cui N; Friend DR; Fedorak RN
Gut; 1994 Oct; 35(10):1439-46. PubMed ID: 7959202
[TBL] [Abstract][Full Text] [Related]
5. Colonic delivery of dexamethasone from a prodrug accelerates healing of colitis in rats without adrenal suppression.
Fedorak RN; Haeberlin B; Empey LR; Cui N; Nolen H; Jewell LD; Friend DR
Gastroenterology; 1995 Jun; 108(6):1688-99. PubMed ID: 7768373
[TBL] [Abstract][Full Text] [Related]
6. Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome.
Nolen HW; Friend DR
Pharm Res; 1994 Dec; 11(12):1707-11. PubMed ID: 7899232
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
[TBL] [Abstract][Full Text] [Related]
8. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone 21-sulfate improves the therapeutic properties of dexamethasone against experimental rat colitis by specifically delivering the steroid to the large intestine.
Kim I; Kong H; Lee Y; Hong S; Han J; Jung S; Jung Y; Kim YM
Pharm Res; 2009 Feb; 26(2):415-21. PubMed ID: 18958401
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro properties of dexamethasone 21-sulfate sodium as a colon-specific prodrug of dexamethasone.
Kim IH; Kong HS; Choi BI; Kim YS; Kim HJ; Yang YW; Jung YJ; Kim YM
Drug Dev Ind Pharm; 2006 Mar; 32(3):389-97. PubMed ID: 16556543
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
McLeod AD; Friend DR; Tozer TN
J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
[TBL] [Abstract][Full Text] [Related]
13. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
[TBL] [Abstract][Full Text] [Related]
14. A novel colon-specific steroid prodrug enhances sodium chloride absorption in rat colitis.
Fedorak RN; Cui N; Friend DR; Madsen KL; Empey LR
Am J Physiol; 1995 Aug; 269(2 Pt 1):G210-8. PubMed ID: 7653560
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
[TBL] [Abstract][Full Text] [Related]
16. Budesonide versus prednisolone retention enemas in active distal ulcerative colitis.
Löfberg R; Ostergaard Thomsen O; Langholz E; Schiöler R; Danielsson A; Suhr O; Graffner H; Påhlman L; Matzen P; Møller-Petersen JF
Aliment Pharmacol Ther; 1994 Dec; 8(6):623-9. PubMed ID: 7696452
[TBL] [Abstract][Full Text] [Related]
17. Drug glycosides: potential prodrugs for colon-specific drug delivery.
Friend DR; Chang GW
J Med Chem; 1985 Jan; 28(1):51-7. PubMed ID: 3965714
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of budesonide enema in patients with distal ulcerative colitis or proctitis.
Danielsson A; Edsbäcker S; Löfberg R; Nilsson A; Nyman-Pantelidis M; Olsson O; Suhr O; Willén R
Aliment Pharmacol Ther; 1993 Aug; 7(4):401-7. PubMed ID: 8218754
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and retrograde colonic spread of budesonide enemas in patients with distal ulcerative colitis.
Nyman-Pantelidis M; Nilsson A; Wagner ZG; Borgå O
Aliment Pharmacol Ther; 1994 Dec; 8(6):617-22. PubMed ID: 7696451
[TBL] [Abstract][Full Text] [Related]
20. Morpholinoalkyl ester prodrugs of diclofenac: synthesis, in vitro and in vivo evaluation.
Tammara VK; Narurkar MM; Crider AM; Khan MA
J Pharm Sci; 1994 May; 83(5):644-8. PubMed ID: 8071813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
